Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
about
Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery.Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma.Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion.Implications of Stoma Formation as Part of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
P2860
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
@en
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
@nl
type
label
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
@en
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
@nl
prefLabel
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
@en
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC.
@nl
P2093
P2860
P1476
Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC
@en
P2093
Arend G J Aalbers
Elisabeth A te Velde
Erienne M V de Cuba
Hendrik J Bonjer
Leonieke J J van Mens
Simon W Nienhuijs
Victor J Verwaal
P2860
P2888
P304
P356
10.1245/S10434-013-3370-2
P577
2013-11-18T00:00:00Z
P5875
P6179
1010627824